Alterations of vinblasine influx in multidrug-resistant lymphoblastic leukaemic CEM cells

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 407-412

  Colin, M ^a   Madoulet, C ^a   Warren, L ^b   Jardillier, J C ^a,c  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b WISTAR INSTITUTE   (United States)

^c INSTITUT JEAN GODINOT   (France)

Author keywords

Efflux; Human leukaemic CEM cells; Influx; MDR modulators; Multidrug resistance; Temperature coefficient; Vinblastine

Indexed keywords

MEMBRANE PROTEIN; NIGERICIN; PROMETHAZINE; TRIFLUOPERAZINE; VERAPAMIL; VINBLASTINE; TRITIUM;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STEADY STATE; CELL CULTURE; COMPARATIVE STUDY; DRUG SCREENING; KINETICS; METABOLISM; TEMPERATURE;

DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KINETICS; LEUKEMIA, LYMPHOCYTIC; TEMPERATURE; TRITIUM; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0029665056     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
2. Juranka PF, Zastawny RL and Ling V: P-glycoprotein: multidrug-resistannce and a superfamily of membrane-associated transport proteins. FASEB J 3: 2583-2592, 1989.
3. Schinkel AH and Borst P: Multidrug resistance mediated by P-glycoproteins. Semin Cancer Biol 2: 213-226, 1991.
4. Bobichon H, Okiemy MG, Broglio C, Ploton D and Dufer J. Adriamycin resistance is characterised by ultrastructural changes in human leukaemic K 562 cells in vitro. Biol Cell 74: 287-293, 1992.
5. Warren L, Jardillier JC and Ordentlich P: Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res 51: 1996-2001, 1991.
6. Hennequin E, Delvincourt C, Pourny C and Jardillier JC: Expression of mdr1 gene in human breast primary tumours and metastases. Breast Cancer Res Treat 26: 267-272, 1993.
7. Gervasoni JE, Field Sz, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA and Taub RN: Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51: 4955-4963, 1991
8. Slapak CA, Lecerf JM, Daniel JC and Leng SB: Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukaemia cells and cytoplasts. J Biol Chem 267: 10638-10644, 1992.
9. Ramu A, Pollard HB and Rosario LM: Doxorubicin resistance in P 388 leukaemia-evidence for reduced drug influx. Int J Cancer 44: 539-547, 1989.
10. Shalinsky Dr, Jekunen AP, Alcarax JE, Christen RD, Kim S, Khatibi S and Howell SB: Regulation of initial vinblastine influx by P-glycoprotein. Br J Cancer 67: 30-36, 1993.
11. Gottesman MM: How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53 747-754, 1993.
12. Grant S, Rausher F, Jakubowski A and Cadman E: Effect of N-(phosphonacetyl)-L-aspartate on S-azacytidine metabolism in P388 and L 1210 cells. Cancer Res 41: 410-414, 1981.
13. Beck WT: Drug accumulation and binding in P-glycoprotein-associated multidrug resistance. In: Molecular and cellular biology of multidrug resistance in tumour cells (Robinson IB, ed). Plenum, New York, 1991, pp 215-227.
14. Gottesman MM, Schoenlein PV, Currier SJ, Bruggemann EP and Pastan I: Biochemical basis for multidrug resistance in cancer. Biochem Mol Aspects Select Cancers 1: 339-371, 192.
15. Besterman Jm, Airhart JA, Woodworth RC and Low RB. Exocytosis of pinocytosed fluid in cultured cells: kinetic evidence for rapid turnover and compartmentation. J Cell Biol 91: 716-721, 1981.
16. Gros P, Crop J and Housman D Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
17. Kellen JA: Drug Resistance, the last frontier? Anticancer REs 11: 917-919, 1991.
18. Tsuruo T: Reversal of multidrug resistance by calcium channel blockers and other agents. In: Molecular and cellular biology of multidrug resistance in tumour cells (Roninson IB, ed) Plenum, New York, 1991, pp 349-372.
19. Domenech C, Fierro-Duran G, Rodriguez L, Grau-Oliete MR and Rivera-Fillat MP: Vincristine cellular pharmacokinetic changes associated with multidrug resistance. Eur J Pharmacol - Env Toxicol Pharmacol Section 248: 49-58, 1993.
20. Higgins CF and Gottesman MM: Is the multidrug transporter a flippase? TIBS 17: 18-21, 1992
21. Sehested M., Skovsgaard T, Van Deurs B and Winter-Niewlsen H: Increased plasma membrane traffic in daunorubicin resistant P 388 leukaemic cells. Efffect of daunorubicin and verapamil. Br J Cancer 56: 747-754, 1987.
22. Fojo A, Akiyama SI, Gottesman MM and Pastan I. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines Cancer Res 45: 3002-3006, 1985.
23. Skovsgaard T: Mechanism of cross-resistance between vincristine and daunomycin in Ehrlich ascites tumour cells. Cancer Res 39: 4722-4725, 1979.
24. Inaba M, Kobayashi H, Sakurai Y and Johnson RH: Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P 388 leukaemia. Cancer Res 48: 2200-2206, 1988.
25. Klohs WD and Steinkampf RW: The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Molec Pharmacol 34: 180-185, 1988.
26. Sirotnak FM, Yag CH, MInes LS and Oribe E: Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids. J Cell Physiol 126: 266-273, 1986.
27. Colin M, Madoulet C and Jardillier JC: Fluorescent probe BCECF/AM gives evidence for a decreased influx process in CEM multidrug resistant cells. In: Proceedings of the XVI International Cancer Congress (Monduzzi, ed). 1994, pp 279-283.
28. Warren L, Jardillier JC, Malarska A and Akeli MG: Increased accumulation of drugs in multrdrug resistant cells induced by liposomes. Cancer Res 52: 3241-3245, 1992.
29. 100 cells. Anticancer Res 14: 2383-2387, 1994.